INTRODUCTION: Patients undergoing major hepatectomy are at increased risk for post-operative morbidity and mortality, and changes in the phenotype of effector cells may predispose these patients to infectious sequelae. METHODS: To better understand post-hepatectomy immune responses, peripheral blood from 15 hepatectomy patients was drawn immediately before and after liver resection and on post-operative days 1, 3, and 5. Circulating monocytes and dendritic cells were analyzed by flow cytometry for quantity, phenotype, activation status, human leukocyte antigen DR (HLA-DR) expression, and toll-like receptor-2 and -4 expression. RESULTS: Major hepatectomy increased the numbers of activated CD16(bright) blood monocytes and the percentage of activated dendritic cells, although monocyte HLA-DR expression was reduced. These results may represent both dysfunctional antigen presentation and pending anergy, as well as cellular priming of immune effector cells. Better understanding of the alterations in innate immunity induced by hepatectomy may identify strategies to reduce infectious outcomes.
INTRODUCTION:Patients undergoing major hepatectomy are at increased risk for post-operative morbidity and mortality, and changes in the phenotype of effector cells may predispose these patients to infectious sequelae. METHODS: To better understand post-hepatectomy immune responses, peripheral blood from 15 hepatectomy patients was drawn immediately before and after liver resection and on post-operative days 1, 3, and 5. Circulating monocytes and dendritic cells were analyzed by flow cytometry for quantity, phenotype, activation status, humanleukocyte antigen DR (HLA-DR) expression, and toll-like receptor-2 and -4 expression. RESULTS: Major hepatectomy increased the numbers of activated CD16(bright) blood monocytes and the percentage of activated dendritic cells, although monocyte HLA-DR expression was reduced. These results may represent both dysfunctional antigen presentation and pending anergy, as well as cellular priming of immune effector cells. Better understanding of the alterations in innate immunity induced by hepatectomy may identify strategies to reduce infectious outcomes.
Authors: James M Devaney; Catherine M Greene; Clifford C Taggart; Tomás P Carroll; Shane J O'Neill; Noel G McElvaney Journal: FEBS Lett Date: 2003-06-05 Impact factor: 4.124
Authors: M M Hagendorens; D G Ebo; A J Schuerwegh; A Huybrechs; H P Van Bever; C H Bridts; L S De Clerck; W J Stevens Journal: Clin Exp Allergy Date: 2003-05 Impact factor: 5.018
Authors: William R Jarnagin; Mithat Gonen; Yuman Fong; Ronald P DeMatteo; Leah Ben-Porat; Sarah Little; Carlos Corvera; Sharon Weber; Leslie H Blumgart Journal: Ann Surg Date: 2002-10 Impact factor: 12.969
Authors: C Meyer; J Walker; J Dewane; F Engelmann; W Laub; S Pillai; Charles R Thomas; I Messaoudi Journal: Clin Exp Immunol Date: 2015-06-29 Impact factor: 4.330
Authors: James C Lee; Michael D Green; Laura A Huppert; Christine Chow; Robert H Pierce; Adil I Daud Journal: Clin Cancer Res Date: 2021-07-20 Impact factor: 12.531